Citius Oncology Ratios (2022-2026) | CTOR

Ratios Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 79.99%80.27%
EBT Margin (Quarter) -133.61%-1,609.84%
EBIT Margin (Quarter) -133.17%-1,716.17%
EBITDA Margin (Quarter) -133.17%-1,716.17%
Operating Margin (Quarter) -133.17%-1,716.17%
Net Margin (Quarter) -140.31%-1,595.98%
FCF Margin (Quarter) -186.48%-229.81%
Efficiency
Inventory Average (Quarter) 11.33M14.86M16.27M19.75M22.46M22.65M
Assets Average (Quarter) 68.50M69.33M58.79M60.18M60.65M48.94M66.78M87.43M90.96M91.57M96.33M105.46M105.34M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -0.19-149.93-4.42-152.62-13.61-246.03-0.11-46.58-0.16-4.16
Times Interest Earned (Quarter) -0.19-149.93-4.42-152.62-13.61-246.03-0.11-46.58-0.16-4.16
Valuation
Enterprise Value (Quarter) -0.29M-0.12M-0.37M-0.03M-0.03M-112.00-112.00-112.00-112.00-3.92M-7.30M-2.63M
Return Ratios
Return on Sales (Quarter) -0.01%-0.16%
Return on Capital Employed (Quarter) -9.75%-10.01%-42.51%-57.06%-68.02%-84.79%-50.23%-36.84%-93.55%
Return on Assets (Quarter) 0.00%0.00%0.00%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%